Zivo Bioscience (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,542 | 274 | 1,799 | 8,902 | 138 |
| Receivables | 2 | 4 | N/A | N/A | N/A |
| TOTAL | $1,635 | $425 | $1,902 | $8,960 | $168 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 8 | 130 | 221 | 30 | 52 |
| TOTAL | $8 | $130 | $221 | $30 | $52 |
| Total Assets | $1,643 | $556 | $2,123 | $8,990 | $220 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 742 | 1,406 | 731 | 894 | 6,740 |
| Accrued Expenses | 66 | 101 | 98 | 96 | 2,465 |
| TOTAL | $2,042 | $2,762 | $2,028 | $2,948 | $11,394 |
| Non-Current Liabilities | |||||
| Long Term Debt | 116 | 0 | N/A | N/A | 122 |
| Deferred Revenues | N/A | N/A | 701 | 1,475 | 1,937 |
| Other Non-Current Liabilities | 0 | 0 | 106 | 0 | 15 |
| TOTAL | $116 | $N/A | $106 | $N/A | $137 |
| Total Liabilities | $2,158 | $2,762 | $2,134 | $2,948 | $11,531 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,759 | 2,778 | 1,570 | 1,570 | 872 |
| Common Shares | 4 | 2 | 2 | 9 | 5 |
| Retained earnings | -136,967 | -123,582 | -115,805 | -107,059 | -99,064 |
| TOTAL | $-515 | $-2,206 | $-11 | $6,042 | $-11,311 |
| Total Liabilities And Equity | $1,643 | $556 | $2,123 | $8,990 | $220 |